Ideas

May 8, 2018

Published by admin_auro at May 8, 2018

Categories

Molecular therapy for cardiomyocyte proliferation and heart regeneration: A pharmaceutical mixture encompassing AM-1241, DH404 and DL-3-n-Butylphthalide decreases tumor suppressor MiR-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up regulation of its target gene, 8/May/2018, 6.57 pm

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory of […]

May 8, 2018

Published by admin_auro at May 8, 2018

Categories

Pancreatic polypeptide-based therapy for blood sugar disease (autoimmune diabetes (TIDM)): Pancreatic polypeptide increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 8/May/2018, 6.48 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]

May 8, 2018

Published by admin_auro at May 8, 2018

Categories

A fibrous way to say no to Diabetes Mellitus: β-glucan, found abundantly in oats, barley and others, augments the expression of FGF19 and FGF1, attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIDM via up regulation of its target gene, 8/May/2018, 12.27 pm

Introduction: What they say A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection of FGF1 […]

April 29, 2018

Published by admin_auro at April 29, 2018

Categories

Lighting your way to treat blood sugar disease: Blue light-based therapy for diabetes (TIIDM): Intense blue light increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 29/April/2018, 7.29 am

Introduction: What they say A study from the Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, […]